When was Novartis founded?

Novartis was founded in 1996 and raised its 1st funding round 12 years after it was founded.

Where is Novartis located?

Novartis is headquartered in Basel, Switzerland. It is registered at Inspire BKC 7th Floor Bandra Kurla Complex, Bandra East, Bandra(East), Mumbai, Bandra, Maharashtra, India, 400051.

How many employees does Novartis have?

As of Apr 30, 2026, the latest employee count at Novartis is 83811.

Is Novartis a funded company?

Novartis is a funded company, having raised an undisclosed amount across 19 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 26, 2008.

When was the latest funding round of Novartis?

Novartis' latest funding was a $***** Grant (prize money) round on Dec 01, 2018, with participation from 1 investor.

What is the annual revenue of Novartis?

Annual revenue of Novartis is $70K as on Dec 31, 2017.

Where does Novartis rank among its competitors?

Novartis ranks 10th amongst 1641 active competitors, of which 115 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Johnson & Johnson, which secured $34M in Feb, 2025.

Who are the top competitors of Novartis?

Novartis' top competitors include AbbVie, Amgen and Gilead. Among them, Johnson & Johnson secured the most recent funding round in February, 2025.

Novartis - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

R&D focused on manufacturing of drugs for multiple therapeutic areas. The Company segments include Pharmaceuticals, which researches, develops, manufactures, distributes, and sells prescription medicines in the therapeutic areas, such as oncology, cardio-metabolic, immunology and dermatology, retina, respiratory, neuroscience, and established medicines; Alcon, which operates through over three franchises Surgical, Ophthalmic Pharmaceuticals and Vision Care, and Sandoz, which develops, manufactures and markets generic pharmaceutical products, follow-on biopharmaceutical products known as biosimilars, and other drug substances.

Website: www.novartis.com/
Social
Email ID: *****@novartis.com
Phone Number: +41 **********
Registered Address: Inspire BKC 7th Floor Bandra Kurla Complex, Bandra East, Bandra(East), Mumbai, Bandra, Maharashtra, India, 400051

Key Metrics

Founded Year

1996

Location

Basel, Switzerland

Stage

Public

Latest Funding Round

Grant (prize money), Dec 01, 2018, $*****

Investors

Digital Pharma Lab & 10 more

Ranked

10^th among 1641 active competitors

Annual Revenue

$70K as on Dec 31, 2017

Employee Count

83,811 as on Apr 30, 2026

Investment & Acquisitions

Excellergy & 161 more

Similar Companies

AbbVie & 1721 more

Exit Details

Public

View Novartis' full profile

Novartis is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NOVARTIS HRVATSKA D.O.O. CIN: 70166062414 , Croatia, Active	Mar 20, 2005	$12.3M (As on Dec 31, 2014)	-
NOVARTIS HEALTHCARE PRIVATE LIMITED CIN: U15202MH1997PTC111257 , India, Active	Oct 13, 1997	$720M (As on Mar 31, 2025)	7534 (As on Feb 29, 2024)
NOVARTIS INDIA LIMITED CIN: L24200MH1947PLC006104 , India, Active	Dec 13, 1947	$47.1M (As on Mar 31, 2025)	53 (As on Mar 01, 2026)
NOVARTIS HEALTHCARE A/S CIN: 20575786 , Denmark, Active	Dec 16, 1997	-	97 (As on Apr 30, 2024)
Endocyte Inc CIN: 1235007 , United States, Active	Dec 10, 2001	$70K (As on Dec 31, 2017)	-	-

Novartis got listed on May 11, 2000.

Click here to take a look at Novartis's IPO in detail

Novartis has raised funding over 19 rounds. Its first funding round was on Aug 26, 2008. Its latest funding round was a Grant (prize money) round on Dec 01, 2018 for $*****. 1 investor participated in its latest round. Novartis has 11 institutional investors.

Here is the list of recent funding rounds of Novartis:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 01, 2018	6577517	Grant (prize money)	3318750	2979774	6448392	2075232
Jun 01, 2018	9512396	Grant (prize money)	3755907	9684132	9796604	Europa
Jul 01, 2017	4999705	Grant (prize money)	3297878	6975543	2499669	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Novartis's funding rounds and investors

The founders of Novartis is Lisa Richter. Vasant Narasimhan, Ulrike Gajek, Gina Conti and Marion Riemenschneider are the CEOs of Novartis.

Here are the details of Novartis' key team members:

Lisa Richter: President / Co-Founder of Novartis.
Vasant Narasimhan: CEO of Novartis.
Contact Info: 2 email addresses

View details of Novartis's Founder profiles and Board Members

Novartis' employee count trend

Novartis has 83,811 employees as of Apr 26. Here is Novartis's employee count trend over the years:

Uncover Novartis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Novartis include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Novartis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Alcor Fund, Berkshire Hathaway & 8 others	81/100
2nd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Amgen Business Development, Gershon Capital ... & 11 others	81/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Temasek & 17 others	80/100
4th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Gershon Capital & 11 others	79/100
5th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Alcor Fund, Castle Investment Management ... & 16 others	76/100
6th	Juno Therapeutics 2013, Seattle (United States), Acquired	Global biopharmaceutical company discovering, developing, and delivering innovative medicines	$317M	RA Capital Management, BB Biotech & 14 others	74/100
7th	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Alcor Fund, Benson Family Private Equity ... & 16 others	72/100
8th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 7 others	72/100
9th	Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public	Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others	-	BB Biotech, Gershon Capital & 7 others	71/100
10th	Novartis 1996, Basel (Switzerland), Public	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, MT Capital & 9 others	70/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Novartis's competitors? Click here to see the top ones

Novartis has made 119 investments in companies including NRG Therapeutics and Octave Bioscience. Novartis has also acquired 43 companies including Excellergy and Avidity Biosciences.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Mar 27, 2026	Acquisition	Excellergy	2020	Palo Alto (United States)
Oct 27, 2025	Acquisition	Avidity Biosciences	2012	San Diego (United States)
Sep 09, 2025	Acquisition	Tourmaline Bio	2021	New York City (United States)